Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Radical perineal prostatectomy]

Akio Matsubara¹, Hiroaki Yasumoto, Kazuaki Mutaguchi

¹Department of Urology, Graduate School of Biomedical Sciences, Hiroshima University.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|February 26, 2003

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development and growth of cavernosal sinusoidal endothelia in the external genitalia of human fetuses.

Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft·2024

Same author

Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells.

International journal of molecular sciences·2023

Same author

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma.

Current urology·2023

Same author

Par14 interacts with the androgen receptor, augmenting both its transcriptional activity and prostate cancer proliferation.

Cancer medicine·2022

Same author

ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial Carcinoma.

Pathobiology : journal of immunopathology, molecular and cellular biology·2022

Same author

Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor.

Current urology·2022